Expression of the human Seipin BSCL2 (Berardinelli-Seip congenital lipodystrophy type 2) complements a yeast null mutant phenotype indicating that the mode of action of Seipin is conserved [30,31]. Here, BSCL2 is linked to congenital generalized lipodystrophy type 2.